Merit Medical Systems reported $820.12M in Debt for its fiscal quarter ending in June of 2026.





Debt Change Date
3M USD 15B 2.45B Sep/2026
Abbott USD 34.05B 20.19B Mar/2026
AngioDynamics USD 6.3M 6.3M Feb/2025
Anika Therapeutics USD 0 0 Mar/2025
AtriCure USD 71.05M 736K Jun/2026
Baxter International USD 9.67B 20M Jun/2026
Becton, Dickinson and Co. USD 16.81B 471M Jun/2026
Boston Scientific USD 12.62B 1.6B Jun/2026
Cooper Companies USD 2.46B 39.5M Mar/2026
Dexcom USD 1.24B 154.7M Sep/2026
Edwards Lifesciences USD 598.8M 105.6M Sep/2026
Globus Medical USD 111.19M 4.03M Jun/2026
Haemonetics USD 1.12B 50.4M Sep/2026
ICU Medical USD 1.15B 79.35M Sep/2026
Insulet USD 962.1M 13.7M Sep/2026
Integra LifeSciences USD 2.05B 9.43M Jun/2026
J&J USD 49.04B 5.95B Jun/2026
Medtronic USD 28.15B 192M Jun/2026
Merit Medical Systems USD 820.12M 1.44M Jun/2026
Olympus JPY 336.52B 102.64B Sep/2026
Pfizer USD 62.67B 523M Sep/2026
STAAR Surgical USD 35.94M 1.35M Jun/2026
Stryker USD 14.18B 16M Sep/2026
Tandem Diabetes Care USD 603.39M 811K Sep/2026
Teleflex USD 2.87B 186.84M Jun/2026
Terumo JPY 389.46B 9.67B Jun/2026
Zimmer Biomet Holdings USD 7.5B 25.2M Sep/2026